CLINICAL TRIALS, STUDIES, DATA

Ocular Therapeutix™ Announces Topline Results for Phase 2 Clinical Trial of OTX-CSI for the Treatment of Dry Eye Disease Did Not Meet Primary Endpoint

The Phase 2, U.S.-based, randomized, double-masked, multi-center, vehicle-controlled clinical trial [...]

By |2021-10-22T17:28:20+00:00October 22, 2021|3rd Party Medical Device Industry News|Comments Off on Ocular Therapeutix™ Announces Topline Results for Phase 2 Clinical Trial of OTX-CSI for the Treatment of Dry Eye Disease Did Not Meet Primary Endpoint
Go to Top